Mcf Advisors LLC Ocuphire Pharma, Inc. Transaction History

Mcf Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$1.8 - $3.25 $1,918 - $3,464	1,066 Added 11.22%	10,565 $20,000
Q1 2022 May 05, 2022	BUY	$2.75 - $4.39 $26,122 - $41,700	9,499 New	9,499 $30,000
Q4 2021 Feb 14, 2022	SELL	$3.4 - $5.19 $32,296 - $49,299	-9,499 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.7 - $13.31 $54,144 - $126,431	9,499 New	9,499 $55,000

2.61M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.